M. Fedyanin

Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry

Richard Cathomas, Dirk Klingbiel, Brandon Bernard et al. · Journal of Clinical Oncology · 2018 · 76 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

Christoph Oing, Karin Oechsle, Andrea Necchi et al. · Annals of Oncology · 2016 · 28 citations

Medicine, Oncology, Pathology +14

A multicenter phase II study of the efficacy and safety of quisinostat (an HDAC inhibitor) in combination with paclitaxel and carboplatin chemotherapy (CT) in patients (pts) with recurrent platinum resistant high grade serous epithelial ovarian, primarily peritoneal or fallopian tube carcinoma cancer (OC).

Sergei Tjulandin, M. Fedyanin, Vladimir Vladimirov et al. · Journal of Clinical Oncology · 2017 · 16 citations

Medicine, Oncology, Pharmacology +17

Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis

Krzysztof Leśniewski-Kmak, Mark Saunders, Harpreet Wasan et al. · Annals of Oncology · 2018 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Human chorionic gonadotropin–positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)

Christoph Seidel, Gedske Daugaard, Tim Nestler et al. · European Journal of Cancer · 2020 · 15 citations

Veterinary Medicine, Endocrinology, Oncology +10